C07D 265/30
Not condensed with other rings
Official title: not condensed with other rings
C07D265/30 (Not condensed with other rings) appears on 1,146 US grants and 1,094 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,146
- Published applications
- 1,094
- Assignees
- 650
- Inventors
- 3,651
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 18 | 0 |
| 1978 | 32 | 0 |
| 1979 | 8 | 0 |
| 1980 | 15 | 0 |
| 1981 | 16 | 0 |
| 1982 | 7 | 0 |
| 1983 | 10 | 0 |
| 1984 | 9 | 0 |
| 1985 | 6 | 0 |
| 1986 | 12 | 0 |
| 1987 | 11 | 0 |
| 1988 | 7 | 0 |
| 1989 | 11 | 0 |
| 1990 | 19 | 0 |
| 1991 | 7 | 0 |
| 1992 | 13 | 0 |
| 1993 | 14 | 0 |
| 1994 | 8 | 0 |
| 1995 | 27 | 0 |
| 1996 | 17 | 0 |
| 1997 | 21 | 0 |
| 1998 | 20 | 0 |
| 1999 | 18 | 0 |
| 2000 | 14 | 0 |
| 2001 | 26 | 5 |
| 2002 | 31 | 33 |
| 2003 | 33 | 21 |
| 2004 | 13 | 30 |
| 2005 | 11 | 47 |
| 2006 | 14 | 38 |
| 2007 | 14 | 25 |
| 2008 | 23 | 16 |
| 2009 | 22 | 39 |
| 2010 | 29 | 60 |
| 2011 | 23 | 46 |
| 2012 | 27 | 32 |
| 2013 | 29 | 52 |
| 2014 | 29 | 44 |
| 2015 | 44 | 56 |
| 2016 | 48 | 61 |
| 2017 | 53 | 60 |
| 2018 | 45 | 46 |
| 2019 | 53 | 54 |
| 2020 | 41 | 64 |
| 2021 | 40 | 44 |
| 2022 | 46 | 43 |
| 2023 | 30 | 55 |
| 2024 | 25 | 52 |
| 2025 | 23 | 45 |
| 2026 | 21 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Derivatives of substituted morpholines and uses thereof29 Sep 2026US 12,747,218 B2Supernus Pharmaceuticals, Inc.
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Methadone Active Agents and Methods of Use Thereof6 Aug 2026US 2026/0226000 A1Ensysce Biosciences Inc.
- Gpr35 modulators30 Jul 2026US 2026/0216198 A1ThirtyFiveBio Limited
- Amyloid targeting agents30 Jul 2026US 2026/0217667 A1Amydis, Inc.
Most cited
By later US patents
- Amide complexes151US 5,693,310 ASchering Corporation · 1997
- Bupropion metabolites and methods of use151US 6,342,496 B12002
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Compounds with activity on muscarinic receptors147US 6,528,529 B1ACADIA Pharmaceuticals Inc. · 2003
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018